{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Pioneering the Future of Cancer Research: A Conversation with Dr. Robert Winn","description":"In this episode of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, engages in an insightful conversation with Dr. Robert Winn, Director and Lippman Chair in Oncology at Massey Comprehensive Cancer Center at Virginia Commonwealth University. They discuss Dr. Winn\u2019s pioneering work in cancer research and health equity, especially focusing on underserved communities. The episode highlights the significance of the Inclusive Excellence initiative Dr. Winn is leading as president of the American Association of Cancer Institutes (AACI), as well as disparities in cancer care in rural areas, the exciting advancements in immunotherapy and molecular therapies, and the essential role of trust and communication in healthcare. The dialogue underscores the critical need for appropriate investment in cancer research to continue making significant strides in reducing cancer mortality and improving patient outcomes. Do you have questions about cancer? Call our Bench to Bedside Hotline at (913) 588-3880 or email us at benchtobedside@kumc.edu, and your comment or question may be shared on an upcoming episode! If you appreciated this episode, please share, rate, subscribe and leave a review. To ensure you get our latest updates, For the latest updates, follow us on the social media channel of your choice by searching for KU Cancer Center. Links from this Episode: Learn more about Dr. Robert Winn Read about the AACI Inclusive Excellence initiative Learn about the National Cancer Institute and the designated cancer centers program ","author_name":"Bench to Bedside","author_url":"http:\/\/benchtobedside.libsyn.com\/website","html":"